DailyIQ
Last updatedUpdating…

MOH·Molina Healthcare, Inc.

$210.68
+1.18 (+0.56%)
High
$216.93
Open
$210.15
Market Cap
11.20B
52W High
$244.89
Low
$207.58
P. Close
$210.68
P/E
23.74
52W Low
$115.00
Fwd P/E
21.50
DailyIQ Est.
$208.44
Inst. Ownership
60.3%
Short Interest
5.40%
Days to Cover
4.8
Technical Score (1D)
55
BULLISH
News Sentiment
69
BULLISH
MOH is setting up for a potential resolution: NEUTRAL at 55 with mixed momentum on the 1D chart. Sentiment at 69 is diverging from the bullish bias, so confirmation still matters. $217.88 is the line bulls need to clear; $201.12 defines the risk if the attempt stalls. Momentum-driven buyers tend to show up only after $217.88 actually breaks, which means the setup can look identical for days before anything changes on the tape. That's the nature of breakout-watch conditions: the NEUTRAL read and mixed momentum describe the pressure building, not the timing of when it releases.
LOW TARGET
$147 -30.2%
2 analysts
MEAN TARGET
$209 -0.7%
19 analysts
HIGH TARGET
$266 +26.3%
5 analysts
PRICE RANGE
$147.00 - $266.00
SB / B / H / S / SS
3/4/17/1/1
DAILYIQ EST.
$208.44 (-1.1%)
Sector
Healthcare
Industry
Healthcare Plans
Exchange
NYQ
Country
United States
Symbol
MOH
Description
Molina Healthcare is a managed care provider specializing in government-sponsored healthcare programs. The company primarily serves low-income populations, offering health plans through Medicaid and Medicare programs across the United States. Molina's value proposition centers on delivering accessible and affordable healthcare solutions to vulnerable communities. Operating through four key segments – Medicaid, Medicare, Marketplace, and Other – the company has established a presence in the healthcare market since its founding in 1980. Headquartered in Long Beach, California, Molina Healthcare focuses on providing essential healthcare services to individuals and families who qualify for government assistance.
Bought (1Y)
0 shares
$0
Sold (1Y)
783 shares
$157K
BRASIER BARBARA L-
Award/Grant304 shares2026-10-01
SOISTMAN FRANCIS S JR-
Award/Grant304 shares2026-10-01
GROHOWSKI LEO P-
Award/Grant304 shares2026-10-01
Lockhart Stephen H-
Award/Grant304 shares2026-10-01
ORLANDO STEVEN J-
Award/Grant304 shares2026-10-01
43/ 100
Bearish
Overall: Bearish
✓Revenue growing year over year
✓Positive net margin
✕Negative operating cash flow
Gross Margin
5.5%
Net Margin
1.0%
Revenue CAGR
17.0%
Current Ratio
1.69x
Debt / Equity
0.93x
Return on Equity
11.6%
Earnings Summary
Molina Healthcare, a managed care provider focused on Medicaid and Medicare programs, serves low‑income populations across the United States, positioning itself within the broader healthcare plans sector. The company’s business model relies on delivering accessible, affordable care through four segments—Medicaid, Medicare, Marketplace, and Other—while maintaining a strong membership base. In the most recent quarters, revenue grew from $10.499 billion in Q4 2024 to $11.147 billion in Q1 2025, and further to $11.427 billion in Q2 2025, reflecting a steady upward trend. EPS, however, showed mixed results: the company missed estimates in Q4 2024 (5.05 vs 5.882), beat them in Q1 2025 (6.08 vs 5.958), and narrowly missed in Q2 2025 (5.48 vs 5.529). The Q3 2025 EPS of 1.84 fell well below the 3.893 estimate, indicating a sharp decline in profitability, while revenue remained flat at $11.477 billion. Historically, Molina has maintained double‑digit revenue growth year over year, with EPS fluctuating around analyst expectations; the company has consistently delivered revenue growth even when earnings missed, suggesting resilience in its core membership base. Recent news highlights a concentration risk: the firm’s narrow focus on Medicaid and Medicare limits diversification relative to peers like UnitedHealth, potentially exposing it to policy and reimbursement shifts. Analysts caution that medical cost ratio and pricing discipline remain weaker, and any adverse regulatory changes could pressure earnings.

EPS

EstBeatMiss
$-3.99$-1.30$1.39$4.08$6.77Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$0.79 - -
Q2'26$1.40$1.51+7.5%
Q1'26$1.94$2.35+21.4%
Q4'25$0.34$-2.75-916.0%
Q3'25$3.89$1.84-52.7%
Q2'25$5.53$5.48-0.9%

Revenue

EstBeatMiss
$10.7B$10.9B$11.1B$11.4B$11.6BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$10.9B - -
Q2'26$10.9B$10.9B-0.2%
Q1'26$10.9B$10.8B-0.8%
Q4'25$11.0B$11.4B+3.7%
Q3'25 - $11.5B -
Q2'25 - $11.4B -

Market Data

MOH Stock Snapshot

NEUTRAL55/100
$210.68+$1.18 (0.6%)
Market cap
11.20B
P/E ratio
23.7
Day range
$207.58 – $216.93
News sentiment
69/100 · Bullish
Analyst target
$209.12 (-0.7%)
Consensus
Hold · 26 analysts
52-week range+83.2% off low · -14.0% from high
$115.00$244.89
Price $210.68 DailyIQ Est. $208.44

MOH sits in the upper part of its 52-week range with the technical picture unresolved. Earnings and guidance carry more weight than macro data at this capitalisation.

Behaviour On Record

What MOH's own history says about today's numbers

Realized volatility (21d)
37.5% 66th pct
Below its peak
-58.4%
vs 200-day average
+14.9%
Up days (1y)
53%

Molina Healthcare, Inc. is currently running 37.5% annualised volatility over the last 21 sessions. Measured against MOH's own 13 years of daily returns rather than a market-wide average, that is the 66th percentile — a little above its own norm, against a typical reading of 31.8%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

MOH is trading -58.4% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -29.6%, and the deepest was -62.1% in 2025. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits +14.9% from its 200-day moving average. Against every other day in its history, that gap ranks at the 68th percentile — a somewhat wider gap than its own norm. Over the past year MOH closed higher on 53% of sessions, and it is currently 4 sessions into a rising streak.

On October specifically: over 13 years of records, MOH finished the month higher 5 of 13 times, with a median return of -1.0% and an average of -1.4%. Its strongest month historically has been May at +3.7% on average, its weakest October at -1.4%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: MOH has opened more than 2% away from the prior close in 138 of 3,267 sessions (4.2% of the time), with the largest gaps running +12.6% and -19.4%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, MOH moved an average of 7.7% in the session after earnings, closing higher 3 of those 3 times, with a median move of +10.5% and a largest of +12.3%.

All figures computed from 3,268 daily closes between 2013-10-15 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against MOH's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of MOH's sector?

Molina Healthcare, Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).

Sector rank
#2 of 12
Sector state
Leading
Sector rotation score
91

Options Market

What is the options market pricing for MOH?

CallsPuts

For Molina Healthcare, Inc.'s nearest expiry (2026-10-16, 2 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 2.96), with at-the-money implied volatility around 38.4%. The options market is pricing roughly a ±3.4% move by that expiry — a range of about $203.81–$218.05.

Put/call ratio (2026-10-16)
2.96
ATM implied volatility
38.4%
Total open interest
7,149
Expected move by 2026-10-16
±3.4% ($203.81–$218.05)

Analyst Rating Changes

Are analysts turning bullish or bearish on MOH?

Wells Fargo most recently reiterated its rating on Molina Healthcare, Inc. to Equal-Weight on Jul 28, 2026 with a price target of $220 (from $235). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Wells Fargo — Equal-Weight
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Jul 28, 2026Wells FargoMaintainedEqual-Weight$235 → $220
Jul 24, 2026Truist SecuritiesMaintainedHold$250 → $225
Jul 24, 2026RBC CapitalMaintainedSector Perform$248 → $218
Jul 24, 2026BarclaysMaintainedUnderweight$184 → $180
Jul 14, 2026TD CowenMaintainedHold$163 → $230
Jul 14, 2026Truist SecuritiesMaintainedHold$205 → $250
Jul 13, 2026Wells FargoMaintainedEqual-Weight$159 → $235
Jul 9, 2026RBC CapitalMaintainedSector Perform$216 → $248
Jul 9, 2026BarclaysMaintainedUnderweight$199 → $184
Jun 23, 2026RBC CapitalInitiatedSector Perform$216
Jun 8, 2026JP MorganMaintainedNeutral$169 → $191
Jun 4, 2026Morgan StanleyMaintainedEqual-Weight$146 → $167

Peers & ETF holders

MOH peers & ETF holders

News Sentiment Analysis

Sentiment gathered from recent headlines

69/100
Strong NegativeNeutralStrong Positive
MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Over the past six months, Molina Healthcare (MOH) has outperformed the S&P 500 by 19.4%, with its share price rising 36.9% to $193.80. The company’s long‑term sales growth of 13.7% CAGR underpins its robust revenue trajectory. Analysts highlight MOH’s focus on low‑income Medicaid and Medicare markets across 21 states as a key driver of sustained demand. The positive performance has sparked debate among investors about whether the current valuation reflects genuine growth or heightened enthusiasm. Overall, the data suggest a solid, if not yet fully priced, upside potential for the stock.
What did this article say?
Molina Healthcare (MOH) has achieved a 4.7% annualized outperformance over the past 15 years, translating into an average annual return of 17.92%. The company’s market capitalization currently stands at a level that reflects this sustained growth. The historical data underscores MOH’s ability to generate superior returns relative to broader market indices. This performance highlights the company’s effective management of its Medicaid portfolio and its resilience in a competitive healthcare environment. The long‑term track record suggests continued value creation for shareholders.
What did this article say?
Diamond Hill Capital’s Q2 2026 investor letter noted a renewed focus on Molina Healthcare (MOH) after recent market pressure. The firm cited MOH’s strong fundamentals and potential for long‑term growth as a key contributor to its portfolio. The letter emphasized that MOH’s business model and regulatory environment position it well for future expansion. This positive assessment reflects confidence in MOH’s strategic direction and resilience amid broader market volatility.
What did this article say?
Zacks analysts identified Molina Healthcare (MOH) as a compelling value investment, citing its strong Zacks Rank and high Value category grade. The firm noted that MOH’s earnings estimates and revisions are favorable, supporting its valuation thesis. Analysts emphasized that MOH’s performance aligns with the broader value investing trend, positioning the company as a top pick for investors seeking undervalued healthcare exposure.
What did this article say?
Molina Healthcare (MOH) is highlighted in a comparative analysis with UnitedHealth Group, underscoring its narrower focus on government‑sponsored programs such as Medicaid, Medicare, and Marketplace plans. The article notes that MOH’s lack of a diversified platform like UnitedHealth’s Optum suite limits its ability to leverage technology, analytics, and pharmacy services for cost control. While MOH’s membership trends remain stable, its medical cost ratio and pricing discipline are less robust compared to UNH, potentially constraining future earnings growth.
What did this article say?
Molina Healthcare announced in February 2026 that it will discontinue its traditional Medicare Advantage Prescription Drug (MAPD) plans effective December 31, 2026, a move that will leave roughly 80,000 members without prescription coverage unless they secure alternative plans before the enrollment deadline. The company’s decision reflects a strategic pivot toward dual‑eligible Medicare beneficiaries, but the eight‑month lag between the investor announcement and the member notice creates a scramble for affected customers and risks late‑enrollment penalties. The exit is expected to reduce MOH’s MAPD revenue stream, increase churn, and potentially erode market share in the Medicare Advantage space.
What did this article say?
Molina Healthcare (MOH) experienced a modest pullback, with the share price sliding to around $197.80 and declining 1.5% on the day and 7.6% over the past week. The decline follows a year‑to‑date share price gain of 10.8%, but the 1‑year total shareholder return remains modest at 8.8% and the 3‑year return has fallen 42.1%, indicating a weaker long‑term base. The recent momentum suggests a potential re‑evaluation of the stock’s valuation relative to its peers.
What did this article say?
Molina Healthcare (MOH) has delivered an average annual return of 11.61% over the past two decades, outperforming the broader market by 2.46% on an annualized basis. The company’s market cap remains robust, reflecting sustained investor confidence. While the data highlights historical strength, it does not signal any immediate change in guidance or operational outlook.
What did this article say?
The Q2 earnings season review positions Molina Healthcare (MOH) within a broader health‑insurance context, noting that while upfront premiums provide stable revenue, profitability hinges on risk assessment and cost control. The sector benefits from an aging population and advances in data analytics, yet faces headwinds from regulatory scrutiny, potential policy shifts, and rising medical inflation. MOH’s performance is tied to these macro drivers, with no immediate earnings surprise or guidance change reported.

Technical Analysis

Real-time indicators across multiple timeframes

55
NEUTRAL
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $6.83B combined position · 13 adding, 12 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
BlackRock, Inc.▲ Buy6,572,15612.29%$1.50B2026-08-07
Vanguard Group Inc▼ Sell6,083,53611.38%$1.06B2026-01-29
AQR Capital Management LLC▲ Buy3,560,6016.66%$806.90M2026-08-14
Capital World Investors▼ Sell2,562,9134.79%$586.14M2026-08-12
FMR LLC (Fidelity)▼ Sell1,871,2903.50%$427.96M2026-08-13
Goldman Sachs Group Inc▲ Buy1,306,5632.44%$298.81M2026-08-14
Wellington Management Group LLP▲ Buy1,267,2072.37%$289.81M2026-08-14
Two Sigma Investments, LP▼ Sell1,266,3382.37%$289.61M2026-08-14
Capital Research Global Investors▲ Buy1,092,2512.04%$249.80M2026-08-12
Morgan Stanley▲ Buy1,007,0681.88%$230.32M2026-08-13
Harris Associates L P▼ Sell957,5001.79%$218.98M2026-08-14
Geode Capital Management, LLC▼ Sell891,7721.67%$204.01M2026-08-12
Invesco Ltd.▲ Buy508,6690.95%$116.33M2026-08-14
Northern Trust Corp▲ Buy386,0640.72%$88.29M2026-08-13
Norges Bank▼ Sell380,6490.71%$87.05M2026-08-12
Renaissance Technologies LLC▲ Buy315,0500.59%$72.05M2026-08-13
Bank of America Corp▼ Sell312,5490.58%$71.48M2026-08-14
D. E. Shaw & Co., Inc.▲ Buy208,0270.39%$47.58M2026-08-14
Citigroup Inc▼ Sell207,2150.39%$47.39M2026-08-03
JPMorgan Chase & Co▼ Sell149,7450.28%$34.92M2026-08-12
Gotham Asset Management, LLC▲ Buy130,5480.24%$29.86M2026-08-14
Susquehanna International Group, LLP▼ Sell107,1530.20%$24.51M2026-08-14
Squarepoint Ops LLC▼ Sell96,9830.18%$22.18M2026-08-14
Millennium Management LLC▲ Buy82,8990.16%$18.96M2026-08-14
Prudential Financial Inc▲ Buy47,2490.09%$10.81M2026-08-12
Q2 2026 flow:2.20M sh bought ($502.35M)2.82M sh sold ($645.28M)net -617.3K sh (−$142.93M)
Congressional Trading Activity
7 disclosed trades · ~$56.0K est. traded value · 3 buys, 4 sells
MemberChamberStateTypeAmountTradedFiled
Gilbert CisnerosHouseCA31▼ Sell$1K - $15K2025-11-122025-12-15
Byron DonaldsHouseFL19▼ Sell$1K - $15K2025-09-042025-10-07
Gilbert CisnerosHouseCA31▲ Buy$1K - $15K2025-08-052025-09-12
Gilbert CisnerosHouseCA31▼ Sell$1K - $15K2025-05-302025-06-06
Rob BresnahanHousePA08▲ Buy$1K - $15K2025-05-152025-06-09
Gilbert CisnerosHouseCA31▲ Buy$1K - $15K2025-04-292025-05-06
Rob BresnahanHousePA08▼ Sell$1K - $15K2025-01-132025-02-13